FdaApplication
ANDA 207455
Identifiers
- fda_app_no: ANDA207455
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2018-04-11 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE | 32MG;25MG | TABLET;ORAL |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE | 32MG;12.5MG | TABLET;ORAL |
| CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE | 16MG;12.5MG | TABLET;ORAL |
3 products